Pulmonary Fibrosis News Columnist and Forum Moderator Charlene Marshall reads an article exploring the effectiveness of Metformin, a well-known diabetes medication, on silica-induced PF.  

Following the publication of a 2018 study on Metformin reducing established lung fibrosis, a team of researchers in China are now evaluating the anti-fibrotic effects of this medication in an induced mouse model. They are hopeful that the findings may encourage the exploration of an inhaled form of Metformin as a potential therapy for those living with PF.

Are you interested in learning more about Pulmonary Fibrosis? If so, please visit: https://pulmonaryfibrosisnews.com

Metformin, for Diabetics, Effectively Treats Models of Silica-induced PF

Pulmonary Fibrosis News is committed to creating a 24-hour news cycle of the latest science and research news related to addressing PF. While there is a great deal of research going on right now for treating and eventually curing PF, that news is rarely reported. Our team of writers and editors are proven professionals in the science and research fields who are committed to sourcing and presenting new research news in a format that patients can easily understand.